Literature DB >> 32809908

The cross-talk between the Hippo signaling pathway and autophagy:implications on physiology and cancer.

Fengyuan Tang1, Gerhard Christofori1.   

Abstract

Organ development is precisely guided by spatiotemporal cross-talks between a variety of signaling pathways regulating cell differentiation, proliferation, growth arrest and physiological cell death. Aberrant signaling inputs invariably lead to tissue dysfunction and to certain conditions, even malignant transformation. In this review, we focus on the functional interplay between the Hippo signaling pathway and autophagy in normal tissue homeostasis and in malignant tumor progression. Mounting experimental evidence for the regulation of cancer cell malignancy and therapy resistance by the functional cross-talk between Hippo signaling and autophagy highlights this signaling axis as a suitable therapeutic target to combat cancer.

Entities:  

Keywords:  Autophagy; Beclin-1; Hippo signaling; therapy response

Mesh:

Year:  2020        PMID: 32809908      PMCID: PMC7644147          DOI: 10.1080/15384101.2020.1806450

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  57 in total

1.  The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.

Authors:  Toshiro Moroishi; Tomoko Hayashi; Wei-Wei Pan; Yu Fujita; Matthew V Holt; Jun Qin; Dennis A Carson; Kun-Liang Guan
Journal:  Cell       Date:  2016-12-01       Impact factor: 41.582

2.  Warts is required for PI3K-regulated growth arrest, autophagy, and autophagic cell death in Drosophila.

Authors:  Sudeshna Dutta; Eric H Baehrecke
Journal:  Curr Biol       Date:  2008-09-25       Impact factor: 10.834

3.  hMOB3 modulates MST1 apoptotic signaling and supports tumor growth in glioblastoma multiforme.

Authors:  Fengyuan Tang; Lei Zhang; Gongda Xue; Debby Hynx; Yuhua Wang; Peter D Cron; Christian Hundsrucker; Alexander Hergovich; Stephan Frank; Brian A Hemmings; Debora Schmitz-Rohmer
Journal:  Cancer Res       Date:  2014-05-28       Impact factor: 12.701

4.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 5.  The Hippo pathway and human cancer.

Authors:  Kieran F Harvey; Xiaomeng Zhang; David M Thomas
Journal:  Nat Rev Cancer       Date:  2013-03-07       Impact factor: 60.716

Review 6.  Metabolic regulation of cell growth and proliferation.

Authors:  Jiajun Zhu; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

7.  Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.

Authors:  Jung-Soon Mo; Zhipeng Meng; Young Chul Kim; Hyun Woo Park; Carsten Gram Hansen; Soohyun Kim; Dae-Sik Lim; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2015-03-09       Impact factor: 28.824

8.  The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.

Authors:  Yael Aylon; Anat Gershoni; Ron Rotkopf; Inbal E Biton; Ziv Porat; Anna P Koh; Xiaochen Sun; Youngmin Lee; Maria-Isabel Fiel; Yujin Hoshida; Scott L Friedman; Randy L Johnson; Moshe Oren
Journal:  Genes Dev       Date:  2016-03-24       Impact factor: 11.361

9.  LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.

Authors:  Fengyuan Tang; Ruize Gao; Beena Jeevan-Raj; Christof B Wyss; Ravi K R Kalathur; Salvatore Piscuoglio; Charlotte K Y Ng; Sravanth K Hindupur; Sandro Nuciforo; Eva Dazert; Thomas Bock; Shuang Song; David Buechel; Marco F Morini; Alexander Hergovich; Patrick Matthias; Dae-Sik Lim; Luigi M Terracciano; Markus H Heim; Michael N Hall; Gerhard Christofori
Journal:  Nat Commun       Date:  2019-12-17       Impact factor: 14.919

10.  Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex.

Authors:  Ning Liang; Chi Zhang; Patricia Dill; Ganna Panasyuk; Delphine Pion; Vonda Koka; Morgan Gallazzini; Eric N Olson; Hilaire Lam; Elizabeth P Henske; Zheng Dong; Udayan Apte; Nicolas Pallet; Randy L Johnson; Fabiola Terzi; David J Kwiatkowski; Jean-Yves Scoazec; Guido Martignoni; Mario Pende
Journal:  J Exp Med       Date:  2014-10-06       Impact factor: 14.307

View more
  2 in total

1.  Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.

Authors:  Yu-Chen Xiang; Peng Peng; Xue-Wen Liu; Xin Jin; Jie Shen; Te Zhang; Liang Zhang; Fang Wan; Yu-Liang Ren; Qing-Qing Yu; Hu-Zi Zhao; Yuan Si; Ying Liu
Journal:  Acta Pharmacol Sin       Date:  2021-09-14       Impact factor: 7.169

2.  YAP activation attenuates toxicarioside G‑induced lethal autophagy arrest in SW480 colorectal cancer cells.

Authors:  Limin Zhou; Jinyan Wang; Jiaqi Liu; Jiantang Liang; Yansong Wang; Qunfang Cai; Yonghao Huang
Journal:  Oncol Rep       Date:  2021-08-30       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.